Associations of SGLT2 genetic polymorphisms with salt sensitivity, blood pressure changes and hypertension incidence in Chinese adults

Hypertens Res. 2023 Jul;46(7):1795-1803. doi: 10.1038/s41440-023-01301-2. Epub 2023 May 9.


Sodium-glucose cotransporter 2 (SGLT2) inhibitors lowers blood pressure (BP) and exert a salutary effect on the salt sensitivity of BP. This study aimed to examine the associations of SGLT2 genetic variants with salt sensitivity, longitudinal BP changes and the risk of incident hypertension in Baoji Salt-Sensitive Study. A total of 514 participants were recruited when the cohort was established in 2004, and 333 participants received a dietary intervention that consisted of a 3-day usual diet followed sequentially by a 7-day low-salt diet and a 7-day high-salt diet. The cohort was then followed up for 14 years to evaluate the longitudinal BP changes and development of hypertension. We found that SGLT2 SNP rs3813007 was significantly associated with the systolic BP (SBP) responses to the low-salt diet. Over the 14 years of follow-up, SNPs rs3116149 and rs3813008 were significantly associated with the longitudinal SBP changes, and SNPs rs3116149, rs3813008, rs3813007 in SGLT2 were significantly associated with incidence of hypertension. Furthermore, gene-based analyses revealed that SGLT2 was significantly associated with hypertension incidence. Our study suggests that SGLT2 genetic polymorphisms may be involved in salt sensitivity and development of hypertension.

Keywords: Blood pressure; Gene polymorphism; SGLT2; Salt sensitivity.

MeSH terms

  • Adult
  • Blood Pressure* / physiology
  • East Asian People*
  • Humans
  • Hypertension* / epidemiology
  • Hypertension* / etiology
  • Hypertension* / genetics
  • Incidence
  • Polymorphism, Single Nucleotide
  • Sodium Chloride, Dietary* / adverse effects
  • Sodium-Glucose Transporter 2 / genetics


  • Sodium Chloride, Dietary
  • Sodium-Glucose Transporter 2